Metformin Inhibits NLRP3 Inflammasome Expression and Regulates Inflammatory Microenvironment to Delay the Progression of Colorectal Cancer

CONCLUSION: Metformin can inhibit the expression of NLRP3 inflammasome, thereby suppressing the expression of inflammation-related factors, reducing the damage of the inflammatory microenvironment to normal cells, and delaying the progression of colorectal cancer.PMID:38347775 | DOI:10.2174/0115748928274081240201060643

Source: Recent Patents on Anti-Cancer Drug Discovery - February 13, 2024 Category: Cancer & Oncology Authors: Gaojie Liu Feixiang Wang Yanlin Feng Hongsheng Tang Source Type: research